RELX Presents Strategy to Accelerate STM Revenue Growth

RELX reported 6% underlying revenue growth in its Scientific, Technical & Medical business for H1 2026, with adjusted operating profit up 8%. The segment contributed 28% of group revenue and 30% of profit. Elsevier saw a 20% rise in article submissions and 7% increase in published articles. The company aims to boost research publishing and product innovation to maintain profit growth ahead of revenue.

Original reporting
Published Nov 4, 2026, 9:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 10:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$RELX
Bullish
high confidence
Mentioned
$RELX
Relevance
7/10
AlphAI data visualization · based on vermoegenszentrum.ch
Decision brief

The 30-second read

$RELXBullishMed
01

Why it matters

The half‑year growth beats prior expectations and may prompt analysts to raise forecasts.

02

Market read

Strong STM performance could lift RELX and peer stocks in the information‑services sector.

03

What to watch

Potential cost pressures from rising content acquisition costs are not addressed.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

RELX is a global provider of information and analytics services; its STM segment accounts for roughly a quarter of total revenue.

Company-level read

Ticker impact

$RELXBullishHigh confidence
Context

RELX reported 6% underlying revenue growth and 8% operating profit increase in its Scientific, Technical & Medical segment for H1 2026.

Expected impact

likely upward pressure as market prices in the stronger-than-expected STM performance

Evidence & confidence

First disclosure of half‑year numbers shows solid growth; no prior public data on these figures.

Market effects

Boosts outlook for the broader scientific, technical and medical publishing sector.

May support European information‑services stocks.

Highlights continued demand for research publishing worldwide.

Counterpoint

If growth slows in later quarters, the current rally could be short‑lived.

Key entities

  • RELX

    Global information and analytics provider

Related articles

$RELXMed

Why is Relx stock climbing today?

Relx PLC ADR stock rose 1.2% in pre-market trading after reporting 7% underlying revenue growth for the nine-month period, with its Legal division leading at 10%. The company also announced a £125M share buyback. The update met investor expectations and maintained full-year targets. The stock's gain contrasts with broader market declines.

$RELXHighAI 8/10

Relx reports 7% underlying revenue growth, reaffirms full-year outlook

Relx reported 7% underlying revenue growth for the first nine months of 2026, driven by AI-powered analytics tools. The company reaffirmed its full-year outlook, expecting strong revenue and profit growth. Legal, Risk, and Scientific divisions led growth, while Exhibitions faced Middle East disruptions. Relx anticipates adjusted operating profit to grow faster than revenue in most divisions.

$RELXMed

Relx Q3 Earnings Call Highlights

Relx (RELX) reported Q3 earnings, with Legal division revenue growing 10% and STM division up 6%. Lexis+ Protégé platform adoption is over 50% in the U.S. LeapSpace, an AI workspace, saw user base double in 90 days. Exhibitions growth was impacted by Middle East disruption. Relx plans to discuss STM growth and AI initiatives in November.

$RELXHighAI 8/10

Relx defies AI disruption fears as growth holds firm

Relx reported a 7% rise in underlying revenue for the first nine months of 2026, with all divisions growing. Legal business saw the highest growth at 10%, driven by AI-powered research tools. The company maintained its full-year forecast for revenue, profit, and earnings per share. Relx argues its specialist data gives it an advantage over AI competitors. Shares have been volatile amid broader sector sell-offs.